LEGN

Legend Biotech Corp ADR

May 20 • 04:00PM ET

28.12

+1.18 4.38 %

Healthcare • Biotechnology • USA • Mid • NASD

| Held by: IBB IEMG IXUS CANC MCHI EEM KOMP FBCG SPEM GNOM

Index	-	P/E	-	EPS (ttm)	-1.36	Insider Own	3.65%	Shs Outstand	185.74M	Perf Week	-1.92%
Market Cap	5.22B	Forward P/E	31.08	EPS next Y	0.90	Insider Trans	-0.15%	Shs Float	176.21M	Perf Month	11.50%
Enterprise Value	4.78B	PEG	-	EPS next Q	0.06	Inst Own	47.63%	Short Float	9.65%	Perf Quarter	53.16%
Income	-250.98M	P/S	4.57	EPS this Y	110.63%	Inst Trans	2.96%	Short Ratio	8.05	Perf Half Y	-5.38%
Sales	1.14B	P/B	5.40	EPS next Y	950.63%	ROA	-15.63%	Short Interest	17.00M	Perf YTD	29.35%
Book/sh	5.21	P/C	6.26	EPS next 5Y	-	ROE	-25.28%	52W High	45.30 -37.92%	Perf Year	-6.48%
Cash/sh	4.49	P/FCF	-	EPS past 3/5Y	16.80% 6.49%	ROIC	-23.24%	52W Low	16.24 73.15%	Perf 3Y	-59.67%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	106.67% 68.87%	Gross Margin	51.52%	Volatility	5.29% 7.22%	Perf 5Y	-25.86%
Dividend TTM	-	EV/Sales	4.18	EPS Y/Y TTM	-13.77%	Oper. Margin	-11.57%	ATR (14)	1.77	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.05	Sales Y/Y TTM	56.70%	Profit Margin	-21.97%	RSI (14)	61.99	Recom	1.35
Dividend Gr. 3/5Y	- -	Current Ratio	2.13	EPS Q/Q	46.50%	SMA20	6.85%	Beta	0.34	Target Price	54.97
Payout	-	Debt/Eq	0.40	Sales Q/Q	56.66%	SMA50	27.58%	Rel Volume	0.64	Prev Close	26.94
Employees	2900	LT Debt/Eq	0.12	Earnings	May 12 BMO	SMA200	7.50%	Avg Volume	2.11M	Price	28.12
IPO	Jun 05, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-1319.51% -0.46%	Trades		Volume	1,382,415	Change	4.38%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-12-26	Downgrade	Rothschild & Co Redburn	Buy → Neutral	$24
Jan-22-26	Downgrade	TD Cowen	Buy → Hold	$21
Jan-07-26	Initiated	Oppenheimer	Outperform	$75
Oct-07-25	Initiated	Cantor Fitzgerald	Overweight	$40
Oct-08-24	Initiated	Redburn Atlantic	Buy	$86
Jun-17-24	Initiated	Truist	Buy	$88
May-24-24	Reiterated	H.C. Wainwright	Buy	$86 → $73
May-23-24	Initiated	Deutsche Bank	Buy	$60
Apr-17-24	Upgrade	Scotiabank	Sector Perform → Sector Outperform	$65
Apr-03-24	Initiated	Cantor Fitzgerald	Overweight	$82
Mar-13-24	Initiated	Raymond James	Outperform	$86
Dec-19-23	Initiated	Scotiabank	Sector Perform
Nov-06-23	Initiated	Goldman	Buy	$90.09
May-25-23	Initiated	William Blair	Mkt Perform	$64
May-22-23	Initiated	Daiwa Securities	Buy
Mar-29-23	Initiated	H.C. Wainwright	Buy	$66
Mar-24-23	Initiated	RBC Capital Mkts	Outperform	$73
Dec-06-22	Initiated	UBS	Buy	$66
Nov-02-22	Initiated	Evercore ISI	Outperform
Nov-01-22	Initiated	Cowen	Outperform

Show Previous Ratings

May-12-26 03:00PM	Legend Biotech Corp (LEGN) Q1 2026 Earnings Call Highlights: Strong CARVYKTI Sales and ... (GuruFocus.com) +10.48%
07:00AM	Legend Biotech Reports First Quarter 2026 Results and Recent Highlights (GlobeNewswire)
May-04-26 08:00AM	Legend Biotech Expands Scientific Advisory Expertise to Inform Future Growth (GlobeNewswire) +12.34%
Apr-28-26 08:00AM	Legend Biotech to Host Investor Conference Call on First Quarter 2026 Results (GlobeNewswire)
Mar-25-26 01:10PM	Johnson & Johnson Exits 3 Biotechs but Keeps Stakes in These Rumored Acquisition Targets (Barrons.com)
03:00AM	Loading…
Mar-16-26 03:00AM	Genscript Biotech Corp (GNNSF) Full Year 2025 Earnings Call Highlights: Record Revenue Growth ... (GuruFocus.com)
Mar-10-26 03:00PM	Legend Biotech Corp (LEGN) Q4 2025 Earnings Call Highlights: Record Growth and Profitability ... (GuruFocus.com)
07:00AM	Legend Biotech Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights (GlobeNewswire)
Feb-24-26 08:00AM	Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2025 Results (GlobeNewswire)
Feb-18-26 02:04AM	Barclays Cite Favorable Long-Term Outlook For Legend Biotech Corporation (LEGN) Despite Near-Term Expectation Revisions (Insider Monkey)
Feb-16-26 12:24PM	FDA Guidance on MRD Negativity Bodes Well for Legend Biotech (LEGN) (Insider Monkey)
Feb-07-26 03:33AM	Legend Biotech (LEGN) Shakes Up Board (Insider Monkey)
Feb-02-26 09:38AM	H.C. Wainwright Highlight Curative Potential of Legend Biotech Corporation (LEGN)'s Carvykti Despite Sales Miss (Insider Monkey)
Jan-26-26 03:14AM	Legend Biotech (LEGN) Advances Cell Therapy Innovation and Expands Oncology Pipeline (Insider Monkey)
Jan-22-26 08:00AM	Here Are Thursdays Top Wall Street Analyst Research Calls: Alphabet, Callaway Golf, Datadog, Hyatt Hotels, Palantir, Texas Instruments, Verizon, and More (24/7 Wall St.) -6.84%
08:00AM	Loading…
Jan-21-26 08:00AM	Legend Biotech to Present CARVYKTI Data at 2026 Tandem Meetings Reinforcing Growing Evidence Supporting Earlier Use (GlobeNewswire) -11.36%
Jan-12-26 08:00AM	Legend Biotech Highlights Recent Business Updates at 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Jan-09-26 03:16AM	Cantor Fitzgerald and RBC Capital Stay Bullish on Legend Biotech (LEGN) (Insider Monkey)
Dec-22-25 06:50AM	Here is Why Legend Biotech (LEGN) Offers Such Promising Upside (Insider Monkey)
Dec-17-25 08:00AM	Legend Biotech to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-11-25 07:44AM	Legend Biotech Corporation (LEGN) is an Outperform on Multiple Myeloma Treatment CARVYKTI Prospects (Insider Monkey)
Dec-09-25 03:31PM	Cancer Study Buoys These Small Biotechs (Barrons.com) -8.58%
Dec-06-25 02:00PM	Legend Biotech Highlights New CARVYKTI Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025 (GlobeNewswire)
Nov-27-25 09:00AM	Legend Biotech Awarded 2025 FIBA Foreign Investor of the Year by Flanders Investment & Trade (GlobeNewswire)
Nov-25-25 08:39AM	William Blair Maintains Hold Rating on Legend Biotech (LEGN) Despite Carvykti Label Safety Concerns (Insider Monkey)
Nov-13-25 12:08PM	Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia (GlobeNewswire)
09:21AM	Company News for Nov 13, 2025 (Zacks)
Nov-12-25 02:03PM	Legend Biotech Corp (LEGN) Q3 2025 Earnings Call Highlights: Record CARVYKTI Sales and ... (GuruFocus.com)
07:00AM	Legend Biotech Reports Third Quarter 2025 Results and Recent Highlights (GlobeNewswire)
Nov-10-25 08:16PM	H.C. Wainwright Remains Bullish on Legend Biotech (LEGN), Cites Solid Growth Trajectory for CARVYKTI Therapy (Insider Monkey)
11:05AM	Loading…
Nov-03-25 11:05AM	Legend Biotech Announces 10 Presentations at the 67th American Society of Hematology (ASH) Annual Meeting (GlobeNewswire)
Oct-29-25 08:00AM	Legend Biotech to Host Investor Conference Call on Third Quarter 2025 Results (GlobeNewswire)
Oct-21-25 09:15AM	CorMedix (CRMD) Surges 19.5%: Is This an Indication of Further Gains? (Zacks)
Oct-17-25 09:54PM	J.P. Morgan Maintains a Buy on Legend Biotech Corporation (LEGN) (Insider Monkey)
Oct-08-25 12:57AM	TD Cowen Reiterates a Buy Rating on Legend Biotech Corporation (LEGN) (Insider Monkey)
Sep-30-25 04:00AM	RBC Capital Reiterates a Buy Rating on Legend Biotech Corporation (LEGN) (Insider Monkey)
Aug-26-25 08:00AM	Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference (GlobeNewswire)
Aug-22-25 11:57PM	RBC Capital Lifts PT on Legend Biotech Corporation (LEGN) to $77 From $75 (Insider Monkey)
05:30AM	China's rise in biotech to potentially lower healthcare costs, life science investor says (South China Morning Post)
Aug-18-25 08:00AM	Legend Biotech Appoints Carlos Santos as Chief Financial Officer (GlobeNewswire)
Aug-12-25 07:22AM	Company News for Aug 12, 2025 (Zacks)
03:03AM	Legend Biotech Corp (LEGN) Q2 2025 Earnings Call Highlights: Record CARVYKTI Sales and ... (GuruFocus.com)
Aug-11-25 10:53AM	Key Inflation Data in Focus (Zacks)
10:12AM	Pre-Markets in Green, Inflation Data, Retail Sales, Q2 Earnings This Week (Zacks)
07:00AM	Legend Biotech Reports Second Quarter 2025 Results and Recent Highlights (GlobeNewswire)
Aug-08-25 09:17AM	Legend Biotech Corp (LEGN) Q2 2025 Earnings Report Preview: What to Expect (GuruFocus.com)
Jul-28-25 08:00AM	Legend Biotech to Host Investor Conference Call on Second Quarter 2025 Results (GlobeNewswire)
Jul-18-25 07:24AM	Legend Biotech (LEGN) Surges 6.0%: Is This an Indication of Further Gains? (Zacks)
Jul-13-25 05:00PM	China Biotechs Stunning Advance Is Changing the Worlds Drug Pipeline (Bloomberg)
Jul-06-25 04:15AM	H.C. Wainwright Maintains a Buy on Legend Biotech (LEGN) With a $75 Price Target (Insider Monkey)
Jun-20-25 04:08PM	The FDA Shake-Up Continues, And Could Impact Genetic Medicines (Investor's Business Daily)
Jun-03-25 10:45AM	Legend Biotech Unveils Groundbreaking 5-Year Survival Data for CARVYKTI in Multiple Myeloma at 2025 ASCO Annual Meeting (GlobeNewswire)
May-22-25 05:15PM	Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT (GlobeNewswire)
May-19-25 08:00AM	Legend Biotech to Host Investor Event During the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire)
May-14-25 09:18AM	Morning Movers: UnitedHealth sinks following CEO exit and outlook suspension (TipRanks) -10.55%
03:06AM	Legend Biotech Corp (LEGN) Q1 2025 Earnings Call Highlights: Record Growth in CARVYKTI Sales ... (GuruFocus.com)
12:24AM	Q1 2025 Legend Biotech Corp Earnings Call (Thomson Reuters StreetEvents)
May-13-25 07:00AM	Legend Biotech Reports First Quarter 2025 Results and Recent Highlights (GlobeNewswire)
May-12-25 09:20AM	What To Expect From Legend Biotech Corp (LEGN) Q1 2025 Earnings (GuruFocus.com)
May-03-25 04:51AM	The Play On Legend Biotech (Seeking Alpha)
May-02-25 12:00PM	What Makes Legend Biotech (LEGN) a New Buy Stock (Zacks)
09:55AM	Wall Street Analysts Think Legend Biotech (LEGN) Could Surge 135.16%: Read This Before Placing a Bet (Zacks)
Apr-29-25 08:00AM	Legend Biotech to Host Investor Conference Call on First Quarter 2025 Results (GlobeNewswire)
Apr-24-25 06:53AM	Legend Biotech Corporation (LEGN): Among Takeover Rumors Hedge Funds Are Buying (Insider Monkey)
Apr-16-25 09:53AM	Legend Biotech (LEGN) Moves 5.1% Higher: Will This Strength Last? (Zacks)
Apr-11-25 12:30AM	Harbor Health Care ETF Q4 2024 Commentary (Seeking Alpha)
Apr-09-25 05:53AM	Pacira (PCRX) Surges 14.7%: Is This an Indication of Further Gains? (Zacks)
Apr-01-25 11:50AM	Biotech stocks slide as Marks resignation seen being negative for sector (TipRanks) -7.10%
Mar-12-25 03:02AM	Legend Biotech Corp (LEGN) Q4 2024 Earnings Call Highlights: Record CARVYKTI Sales and ... (GuruFocus.com)
01:34AM	Q4 2024 Legend Biotech Corp Earnings Call (Thomson Reuters StreetEvents)
Mar-11-25 09:30AM	Compared to Estimates, Legend Biotech (LEGN) Q4 Earnings: A Look at Key Metrics (Zacks) +9.29%
07:00AM	Legend Biotech Reports Fourth Quarter and Full Year 2024 Results and Recent Highlights (GlobeNewswire)
Feb-25-25 08:00AM	Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results (GlobeNewswire)
Feb-23-25 01:29PM	Why Legend Biotech Corporation (LEGN) is the Most Oversold Pharma Stock to Buy According to Analysts (Insider Monkey)
Feb-21-25 09:43AM	Market Concerns Put Pressure on Legend Biotech Corporation (LEGN) Shares (Insider Monkey)
Feb-20-25 12:18PM	Legend Biotech Corporation (LEGN): One of the Most Oversold Healthcare Stocks to Buy Now (Insider Monkey)
Feb-13-25 02:06PM	Is Legend Biotech (LEGN) the Best Mid-Cap Growth Stock to Buy According to Analysts? (Insider Monkey)
Feb-08-25 09:29AM	Why Legend Biotech Corporation (LEGN) Is Among the Best Healthcare Stocks To Buy According to Analysts (Insider Monkey)
Jan-30-25 05:01PM	Heres Why Legend Biotech Corporation (LEGN) Will Double in 2025 (Insider Monkey)
Jan-17-25 11:04AM	Legend Biotech Corporation (LEGN): The Biotech Stock with Biggest Upside Potential (Insider Monkey)
Dec-19-24 08:01AM	Legend Biotech to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-11-24 07:22AM	Legend Biotechs CARVYKTI® Boosts Myeloma Treatment Success (TipRanks) -5.44%
Dec-09-24 07:35PM	CARVYKTI Significantly Improved Minimal Residual Disease Negativity Compared to Standard of Care for Patients with Relapsed or Refractory Multiple Myeloma (GlobeNewswire) -8.96%
04:22PM	Arcellx And Legend Bio Trade Jabs In Multiple Myeloma. But Only One Pulls Ahead. (Investor's Business Daily)
Nov-27-24 10:02AM	Why Is Legend Biotech Corp. (LEGN) Among the Best Up and Coming Stocks to Buy According to Analysts? (Insider Monkey)
Nov-22-24 07:31AM	Legend Biotech Corp. (LEGN): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts (Insider Monkey)
Nov-21-24 05:28PM	Why Is Legend Biotech Corporation (LEGN) Among the Worst Performing Biotech Stocks in 2024? (Insider Monkey)
Nov-13-24 03:28AM	Q3 2024 Legend Biotech Corp Earnings Call (Thomson Reuters StreetEvents)
02:07AM	Legend Biotech Corp (LEGN) Q3 2024 Earnings Call Highlights: CARVYKTI's Impressive Growth Amid ... (GuruFocus.com)
Nov-12-24 09:30AM	Legend Biotech (LEGN) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
07:00AM	Legend Biotech Reports Third Quarter 2024 Results and Recent Highlights (GlobeNewswire)
Nov-11-24 09:55AM	Legend Biotech (LEGN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now (Zacks)
07:04AM	Legend Biotech Corp (LEGN) Q3 2024 Earnings Report Preview: What to Look For (GuruFocus.com)
Nov-07-24 07:30AM	Legend Biotech to Host Investor Event During the 66th American Society of Hematology (ASH) Annual Meeting and Exposition (GlobeNewswire)
Nov-05-24 09:10AM	Legend Biotech to Unveil Minimal Residual Disease Data from Landmark CARTITUDE-4 Trial in Multiple Myeloma (GlobeNewswire)
Nov-04-24 07:30AM	Legend Biotech Appoints Alan Bash as President of CARVYKTI (GlobeNewswire)
Oct-24-24 09:55AM	Wall Street Analysts Believe Legend Biotech (LEGN) Could Rally 90.83%: Here's is How to Trade (Zacks)
08:00AM	Legend Biotech to Host Investor Conference Call on Third Quarter 2024 Results (GlobeNewswire)
Oct-16-24 03:45PM	Is Legend Biotech Corporation (LEGN) the Most Promising Biotech Stock According to Hedge Funds? (Insider Monkey)
Oct-03-24 07:30AM	Legend Biotech to Establish New, State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia (GlobeNewswire)

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

CEO & DirectorDr. Ying Huang Ph.D.

Chief Financial OfficerMr. Carlos Santos

Vice President of FinanceMs. Jessie Yeung M.B.A.

General CounselMr. James Pepin J.D.

J.D.Ms. Ananda Elizabeth Martin Esq.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Huang Ying	Chief Executive Officer	Mar 25 '26	Sale	8.77	9,936	87,139	247,438	Mar 27 04:25 PM
Huang Ying	Officer	Mar 26 '26	Proposed Sale	17.54	4,968	87,149		Mar 26 04:27 PM
Yeung Jessie	Officer	Mar 26 '26	Proposed Sale	17.54	1,862	32,663		Mar 26 04:20 PM
Huang Ying	Officer	Dec 26 '25	Proposed Sale	22.52	64,339	1,449,074		Dec 29 07:28 AM
Sanders Corazon (Corsee) D.	Director	Dec 24 '25	Proposed Sale	22.77	969	22,064		Dec 29 06:45 AM
Huang Ying	Officer	Dec 24 '25	Proposed Sale	22.95	61,467	1,410,606		Dec 29 06:40 AM
GenScript Corporation	Affiliate	Nov 17 '25	Proposed Sale	30.29	203,586	6,166,620		Nov 17 05:50 PM
Casey Patrick John	Director	Sep 26 '25	Proposed Sale	33.28	1,000	33,285		Sep 26 04:24 PM
Huang Ying	Officer	Sep 24 '25	Proposed Sale	33.00	1,370	45,210		Sep 24 10:02 AM
Huang Ying	Officer	Sep 23 '25	Proposed Sale	33.98	1,357	46,112		Sep 23 03:13 PM
Yeung Jessie	Officer	Sep 23 '25	Proposed Sale	33.98	474	16,107		Sep 23 03:13 PM
Sanders Corazon (Corsee) D.	Director	Sep 23 '25	Proposed Sale	34.00	307	10,438		Sep 23 09:47 AM
Huang Ying	Officer	Jul 23 '25	Proposed Sale	45.04	15,291	688,723		Jul 23 04:11 PM
Yeung Jessie	Officer	Jul 23 '25	Proposed Sale	45.00	642	28,890		Jul 23 12:00 PM
Casey Patrick John	Director	Jun 26 '25	Proposed Sale	33.23	1,000	33,234		Jun 26 11:21 AM
Huang Ying	Officer	Jun 25 '25	Proposed Sale	33.72	12,119	408,653		Jun 25 10:31 AM
Huang Ying	Officer	Jun 24 '25	Proposed Sale	34.60	11,810	408,600		Jun 24 04:23 PM
Sanders Corazon (Corsee) D.	Director	Jun 24 '25	Proposed Sale	34.37	307	10,552		Jun 24 10:05 AM
Casey Patrick John	Director	Jun 06 '25	Proposed Sale	32.32	1,000	32,320		Jun 06 11:18 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LEGN

Legend Biotech Corp ADR

Upgrade your Finviz experience